Triple-negative breast cancer (TNBC) is an aggressive subtype with the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2). Here, ERBB2 is linked to triple-negative breast carcinoma.